We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:RAPP
​
​
logo

Rapport Therapeutics (RAPP)

Nasdaq • RAPP • US75383L1026

25.93Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 6.8% of free float is sold short, 2.1 days to cover, cost to borrow 0.82%.

Market Cap

1.53b USD | # 4362 in US

Volume

722.96k shares | 27.57m USD

Shares Outstanding

59.17m

Free Float Shares

78.05% | 46.18m

News

RAPP key data

Rapport Therapeutics (Nasdaq: RAPP) has a market capitalization of $1.53B. Last close $25.93 (as of 2026-11-05); 52-week range $22.06 to $52.93. ORTEX data as of 2026-11-03: short interest is 6.79% of free float, 2.1 days to cover and the average cost to borrow is 0.82%.

  • RAPP news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.